ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Internal Medicine

Top Internal Medicine Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
THOMAS HALLORAN MD

Internal Medicine

22,561

$1.11M

1351
1155 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $60

TIBOR KOPJAS M.D.

Internal Medicine

48,270

$2.91M

1752
1486 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $60

LUIS DEVENECIA MD

Internal Medicine

29,485

$1.43M

874
735 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $60

MARK MEEKER D. O.

Internal Medicine

21,069

$1.43M

879
728 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $60

DHAVAL THAKKAR M.D.

Internal Medicine

24,065

$1.35M

887
788 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $60

YONG CHUN MD

Internal Medicine

23,944

$1.28M

672
644 are 65+

N/A

12%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $60

CHRISTOPHER GREEN M.D.

Internal Medicine

13,162

$1.1M

593
541 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 25%

$83
Average prescription price

Avg: $60

SYED ATHER M.D.

Internal Medicine

22,693

$1.06M

1052
705 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $60

WILLIAM BOBLICK MD

Internal Medicine

13,996

$898K

620
545 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $60

CHRIS CHON MD

Internal Medicine

17,841

$897K

807
739 are 65+

N/A

7%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $60

KEITH SMITH M.D.

Internal Medicine

14,942

$888K

572
521 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $60

RAJAN PATEL M.D.

Internal Medicine

12,424

$871K

665
630 are 65+

N/A

9%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$70
Average prescription price

Avg: $60

JOHN DORSEY MD

Internal Medicine

13,493

$816K

645
541 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $60

ROBERT MAGUIRE MD

Internal Medicine

12,964

$807K

672
538 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $60

DANIEL HERDEMAN MD

Internal Medicine

14,339

$779K

683
558 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $60

THOMAS KOURI M.D.

Internal Medicine

16,979

$746K

701
648 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $60

DAVID REEM MD

Internal Medicine

13,207

$735K

567
529 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $60

LAWRENCE PANKAU MD

Internal Medicine

13,583

$724K

533
504 are 65+

N/A

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $60

ROBERT RINGHOFER M.D.

Internal Medicine

12,542

$703K

813
747 are 65+

N/A

10%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $60

ROGER FULTON MD

Internal Medicine

11,583

$686K

686
635 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $60

MICHAEL MARZEC MD

Internal Medicine

9,522

$351K

480
446 are 65+

N/A

8%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$37
Average prescription price

Avg: $60

VADIM EDELSTEIN M.D.

Internal Medicine

26,100

$1.44M

616
558 are 65+

N/A

8%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $60

MARIO COTE M.D.

Internal Medicine

20,589

$1.38M

753
697 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $60

NIDAL SHAWAHIN MD

Internal Medicine

23,053

$1.25M

772
609 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $60

BHARAT PATEL SC

Internal Medicine

23,307

$1.15M

749
602 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $60

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank